DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Clark JI, Atkins MB, Urba WJ, Creech S, Figlin RA, Dutcher JP, Flaherty L, Sosman JA, Logan TF, White R, Weiss GR, Redman BG, Tretter CP, McDermott D, Smith JW, Gordon MS, Margolin KA.
Adjuvant high-dose bolus interleukin-2 for patients with
high-risk renal cell carcinoma: a cytokine working group randomized trial.
J Clin Oncol 2003; 21: 3133-3140
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.